Diverse but desolate landscape of gut microbial azoreductases: A rationale for idiopathic IBD drug response.
Ontology highlight
ABSTRACT: Prodrugs reliant on microbial activation are widely used but exhibit a range of efficacies that remain poorly understood. The anti-inflammatory compound 5-aminosalicylic acid (5-ASA), which is packaged in a variety of azo-linked prodrugs provided to most Ulcerative Colitis (UC) patients, shows confounding inter-individual variabilities in response. Such prodrugs must be activated by azo-bond reduction to form 5-ASA, a process that has been attributed to both enzymatic and non-enzymatic catalysis. Gut microbial azoreductases (AzoRs) are the first catalysts shown to activate azo-linked drugs and to metabolize toxic azo-chemicals. Here, we chart the scope of the structural and functional diversity of AzoRs in health and in patients with the inflammatory bowel diseases (IBDs) UC and Crohn's Di
SUBMITTER: Simpson JB
PROVIDER: S-EPMC10132220 | biostudies-literature | 2023 Jan-Dec
REPOSITORIES: biostudies-literature
ACCESS DATA